Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
138.77
+7.43 (5.66%)
At close: Oct 9, 2026, 4:00 PM EDT
139.99
+1.22 (0.88%)
After-hours: Oct 9, 2026, 6:57 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $2 billion as of October 9, 2026. It is the 6,764th most valuable company in the world and the 1,778th biggest in the United States. Its market cap has increased by 141.53% in one year.
Market Cap
2.00B
Enterprise Value
1.77B
1-Year Change
141.53%
Global Rank
Country Rank
#1,778 United States
Category
ChartMarket Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $2.00B, an increase of 1,288.81%. That is a compound annual growth rate of 326.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.00B | 61.39% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 2.11B |
| Novavax | 2.10B |
| Mineralys Therapeutics | 2.07B |
| Vericel | 2.05B |
| ADARx Pharmaceuticals | 1.99B |
| Fortrea Holdings | 1.98B |
| Vir Biotechnology | 1.98B |
| Maravai LifeSciences Holdings | 1.93B |